HALOZYME THERAPEUTICS, INC. (HALO)


Stock Price Forecast

May 20, 2024


Forecasted Returns

7 Days Predict

30 Days Predict

90 Days Predict


Forecasted Market-Excess Returns

7 Days Predict

30 Days Predict

90 Days Predict

Loading HALOZYME THERAPEUTICS, INC. chart...

About the Company

Halozyme Therapeutics, Inc. is an American biotechnology company. It develops oncology therapies designed to target the tumor microenvironment. The company was founded in 1998 and went public in 2004. Halozyme is headquartered in San Diego, California.

Exchange

Nasdaq

$60M

Total Revenue

452

Employees

$6B

Market Capitalization

21.02

Price/Earning ratio

Fundamental Data and Insider Transactions (Quarterly data) Full Screen

Loading the fundamentals chart...

Latest $HALO News

We don't have any news on HALOZYME THERAPEUTICS, INC. at the moment.

Latest Neutral (free) Forecasts

STRONG BUY BUY NEUTRAL SELL STRONG SELL ALL

Loading the latest forecasts...

My Portfolio

Loading your portfolio...